ACADIA Pharmaceuticals Inc. vs Dover Corp — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.45 (market cap $5.07B), while Dover Corp trades at $208.79 (market cap $28.07B). The key difference: Dover Corp is far larger — about 5.5× ACADIA Pharmaceuticals Inc.'s market cap, and Dover Corp pays a 1.01% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | DOV | |
|---|---|---|
Market Cap | $5.07B | $28.07B |
Sector | Health | Industrials |
52-Week High | $29.41 | $233.31 |
52-Week Low | $20.06 | $161.16 |
Enterprise Value | $4.19B | $29.58B |
Dividend Yield | — | 1.01% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →